Correlation Between AbL Diagnostics and Valbiotis SAS

Can any of the company-specific risk be diversified away by investing in both AbL Diagnostics and Valbiotis SAS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbL Diagnostics and Valbiotis SAS into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AbL Diagnostics SA and Valbiotis SAS, you can compare the effects of market volatilities on AbL Diagnostics and Valbiotis SAS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbL Diagnostics with a short position of Valbiotis SAS. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbL Diagnostics and Valbiotis SAS.

Diversification Opportunities for AbL Diagnostics and Valbiotis SAS

-0.49

Correlation Coefficient

AbL Diagnostics  Valbiotis SAS

Very good diversification

The 3 months correlation between AbL and Valbiotis is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding AbL Diagnostics SA and Valbiotis SAS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valbiotis SAS and AbL Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbL Diagnostics SA are associated (or correlated) with Valbiotis SAS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valbiotis SAS has no effect on the direction of AbL Diagnostics i.e., AbL Diagnostics and Valbiotis SAS go up and down completely randomly.

Pair Corralation between AbL Diagnostics and Valbiotis SAS

Assuming the 90 days trading horizon AbL Diagnostics SA is expected to under-perform the Valbiotis SAS. But the stock apears to be less risky and, when comparing its historical volatility, AbL Diagnostics SA is 2.53 times less risky than Valbiotis SAS. The stock trades about -0.15 of its potential returns per unit of risk. The Valbiotis SAS is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  133.00  in Valbiotis SAS on September 26, 2024 and sell it today you would earn a total of  6.00  from holding Valbiotis SAS or generate 4.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

AbL Diagnostics SA  vs.  Valbiotis SAS

AbL Diagnostics SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AbL Diagnostics SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Valbiotis SAS

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Valbiotis SAS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Valbiotis SAS may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with AbL Diagnostics and Valbiotis SAS

The main advantage of trading using opposite AbL Diagnostics and Valbiotis SAS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbL Diagnostics position performs unexpectedly, Valbiotis SAS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valbiotis SAS will offset losses from the drop in Valbiotis SAS's long position.

The idea behind AbL Diagnostics SA and Valbiotis SAS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.